Market Place
Sourcing Support
Ironwood makes bid for $1B GI drug with subgroup data
29 Oct 2024 //
FIERCE BIOTECH
Ironwood Presents Apraglutide SBS-IF Data At DDW Late-Breaker
21 May 2024 //
BUSINESSWIRE
Ironwood: Apraglutide SBS-IF Data At DDW 2024
01 May 2024 //
BUSINESSWIRE
Ironwood spies new frontier for $1B drug in exploratory trial
29 Mar 2024 //
FIERCE BIOTECH
Ironwood Results from Ph II Trial of Apraglutide in Patients with SR GI aGVHD
28 Mar 2024 //
BUSINESSWIRE
Ironwood`s bowel disease drug meets main goal of late-stage study
01 Mar 2024 //
REUTERS
Ironwood Announces Positive Results from Phase III of Once-Weekly Apraglutide
29 Feb 2024 //
BUSINESSWIRE
Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition
16 Oct 2023 //
BUSINESSWIRE
VectivBio and Asahi Kasei Pharma Announce the Start of a PI Study of Apraglutide
13 Mar 2023 //
GLOBENEWSWIRE
VectivBio Reports +VE Interim Clinical from STARS Nutrition, Ph2 Apraglutide
13 Oct 2022 //
GLOBENEWSWIRE
VectivBio Presents Preclinical Data Supporting Apraglutide for Acute GvHD
23 Mar 2022 //
GLOBENEWSWIRE
VectivBio Announces Successful Opening of US IND for Apraglutide
20 Oct 2021 //
GLOBENEWSWIRE
VectivBio Receives FDA Orphan Drug Designation for Apraglutide
24 Jun 2021 //
GLOBENEWSWIRE
Hyloris Successfully Renegotiates License Agreements with the Alter Pharma Group
24 Jun 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.